1. Recognize globalization of women’s health based on new data from the World Health Organization reviewing the prevalence of CVD in women throughout the world and the presumed causes and subsequent morbidity and mortality.
2. Identify risk factors for CVD and their different implications in the female vs. the male population and discussion of cardiac markers.
3. Identify high risk populations for the development of atherosclerosis specifically discussing Metabolic Syndrome and its subcategories of hypertension, diabetes, hyperlipidemia, hypertriglyceridemia and central obesity.
4. Discuss new medications available for diabetes and obesity.
5. Discuss the importance of sex specific data in cardiovascular clinical trials.
6. Understand the rationale and hypotheses of the Women's Health Initiative Clinical Trials and apply the findings to the clinical care of postmenopausal women.
7. Review smoking implications in the development of cardiovascular disease.
8. Review current LDL guidelines and the impact on patient care.